Cases

OPINION BY FORD ELLIOTT, P.J.E.: Timothy Stange ("Stange"), plaintiff in the court below, and defendants, Janssen Pharmaceuticals, Inc. ("Janssen"), Johnson & Johnson, and Janssen Research & Development, LLC, 1 have taken cross-appeals from the judgment entered in favor of Stange in the amount of $535,106.17. Stange,

WOLF, D.J. *339I. INTRODUCTION Plaintiff Janssen Biotech, Inc. ("Janssen") alleges that defendants Celltrion Healthcare, Co., Ltd. and Celltrion, Inc. (together, "Celltrion"), and Hospira, Inc. ("Hospira") have infringed U.S. Patent

374 F.Supp.2d 263 (2004) JANSSEN PHARMACEUTICAL N.V. et al, Plaintiffs, v. EON LABS MANUFACTURING, INC., Defendant. No. 01-CV-2322 (NG)(MDG). United States District Court, E.D. New York. July 28, 2004. *264 *265 George F. Pappas, Venable, LLP, Washington, DC, Jeffrey I.D. Lewis, Patterson, Bel

353 F.Supp.2d 231 (2005) PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, Plaintiff, v. John R. NICHOLAS, in his official capacity as Commissioner of the Department of Human Services for the State of Maine, and G. Steven Rowe, in his official capacity as Attorney General for the State of Maine, Defendants. No. 00-157-B-H, No. 04-161-S. United States District Court, D. Rhode Island.

Lourie, Circuit Judge. Plaintiffs-Appellants (collectively, "Sanofi") appeal from the judgment of the U.S. District Court for the District of New Jersey holding, after a bench trial, claims 7, 11, 14-16, and 26 of U.S. Patent 8,927,592 (the " '592 patent") invalid as obvious. Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC , No. 14-7869 (D.N.J. Dec. 19, 2017) ("

609 F.Supp.2d 1282 (2009) EXHIBIT ICONS, LLC et al, Plaintiffs, v. XP COMPANIES, LLC, et al, Defendants. No. 07-80824-CIV. United States District Court, S.D. Florida. March 26, 2009. *1287 Mark Robert Vogel, Mark R. Vogel, P.A., Hollywood, FL, Steven Frederick Samilow, Weston, FL, for Plaintiffs. Steven Neil Lippman, Roths

PROST, Chief Judge. Appellants Sanofi, Aventisub LLC, Re-generan Pharmaceuticals Inc., and Sanofi-Aventis U.S., LLC (collectively, “Appellants”) appeal from a final judgment of the district court holding U.S. Patent Nos. 8,829,165 (“’165 patent”) and 8,859,741 (“’741 patent”) not invalid and granting a permanent injunction enjoining sales of Appellants’

ORDER CINDY K. JORGENSON, District Judge. Plaintiffs Joshua David Mellberg, LLC, dba J.D. Mellberg Financial, and Joshua David Mellberg filed a First Amended Complaint asserting 11 counts against various Defendants. (Doc. 9, FAC) Four motions are now pending before the Court: (1) Partial Motion to Dismiss filed by Defendants Jovan Will and Tree Fine (Doc. 22); (2) Motion to Dismiss filed by Defendant the Imp

*1216RULING ON DEFENDANTS’ MOTION FOR JUDGMENT ON THE PLEADINGS BASED ON UNPA-TENTABILITY UNDER 35 U.S.C. § 101 GEORGE H. WU, District Judge. I. Background The Court is presiding over two sets of consolidated patent infringement cases filed by Plaintiff McRO, Inc., d.b.a. Planet Blue (“Plaintiff” or “Planet Blue”): the

Justice THOMAS delivered the opinion of the Court. * *1841 We granted certiorari in these consolidated cases to decide whether the United States Forest Service has authority under the Mineral Leasing Act,

PUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 19-2233 MAYOR AND CITY COUNCIL OF BALTIMORE; GOVERNMENT EMPLOYEES HEALTH ASSOCIATION, on behalf of itself and all others similarly situated, Plaintiffs - Appellants, v. ACTELION PHARMACEUTICALS LTD.; ACTELION PHARMACEUTICALS US, INC.; JANSSEN RESEARCH & DEVELOPMENT, L

FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT ACRES BONUSING, INC; JAMES No. 20-15959 RAYMOND ACRES, Plaintiffs-Appellants, D.C. No. v. 3:19-cv-05418- WHO LESTER JOHN MARSTON; RAPPORT AND MARSTON, an association of attorneys; DAVID JOSEPH RAPPORT; OPINION COOPER DEMARSE; ASHLEY BURRELL; KOSTAN LATHOURIS; BOUTIN JONES,

Anthony W. Ishii, SENIOR DISTRICT JUDGE The case stems from the death of Agapita Marroquin after she had taken the generic prescription drug amiodarone. Plaintiff Gilbert Marroquin, Mrs. Marroquin's husband, brings seven claims under California law against Defendants Pfizer, Inc. ("Pfizer") and Mylan Institutional, Inc. ("Mylan") for strict products liability, negligence

OPINION & ORDER PAUL A. ENGELMAYER, District Judge. In these four related cases, George Peti-to, Anita Petito, and Connective Licensing, LLC allege that Puritan’s Pride, Inc., Rexall Sundown, Inc., Nature’s Bounty, Inc., and Physiologies, LLC, respectively, have each infringed U.S. Patent No. 6,645,948 (“the '948 patent”), entitled “Nutritional Composition for the Treatment of Connective Ti

SAYLOR, C.J., BAER, TODD, DONOHUE, DOUGHERTY, WECHT, MUNDY, JJ. OPINION JUSTICE DONOHUE *377 In this discretionary appeal, we consider whether the Commonwealth Court erred in reversing the decision of the Lycomin

348 F.Supp.2d 713 (2004) ORTHO-McNEIL PHARMACEUTICAL, INC., Johnson & Johnson Pharmaceutical Research & Development, LLC, and Daiichi Pharmaceutical Co., Ltd., Plaintiffs, v. MYLAN LABORATORIES, INC. and Mylan Pharmaceuticals, Inc., Defendants. No. CIV.A. 1:02CV32. United States District Court, N.D. West Virginia. December 23, 2004.

Case: 20-1037 Document: 97 Page: 1 Filed: 07/01/2020 United States Court of Appeals for the Federal Circuit ______________________ IMMUNEX CORPORATION, AMGEN MANUFACTURING, LIMITED, Plaintiffs-Appellees HOFFMANN-LA ROCHE INC., Plaintiff v. SANDOZ INC., SANDOZ INTERNATIONAL GMBH, SANDOZ GMBH, Defendants-Appellants

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued September 21, 2021 Decided January 4, 2022 No. 20-7077 JOSHUA ATCHLEY, ET AL., APPELLANTS v. ASTRAZENECA UK LIMITED, ET AL., APPELLEES Appeal from the United States District Court for the District of Columbia (No. 1:17

WILLIAM C. BRYSON, UNITED STATES CIRCUIT JUDGE *572BACKGROUND This is a Hatch-Waxman Act case. The plaintiffs, Pernix Ireland Pain DAC and Pernix Therapeutics, LLC, (collectively, "Pernix") have sued the defendant, Alvogen Malta Operations Ltd. ("Alvogen") for patent infringement under

310 F.Supp.2d 610 (2004) ALZA CORPORATION and Janssen Pharmaceutica, Inc. Plaintiffs, v. MYLAN LABORATORIES, INC., Mylan Technologies, Inc., and Mylan Pharmaceuticals, Inc., Defendants. No. 2:02-CV-20, 2:02-CV-213. United States District Court, D. Vermont. March 25, 2004. *611 *612